Resultats de la cerca - Mark Rogers‐Evans
- Mostrar 1 - 3 resultats de 3
-
1
Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX<sub>2</sub> receptor per P. Malherbe, Edilio Borroni, Luca Gobbi, Henner Knust, Matthias Nettekoven, Emmanuel Pinard, Olivier Roche, Mark Rogers‐Evans, JG Wettstein, J‐L Moreau
Publicat 2009Artigo -
2
Spirocyclic Oxetanes: Synthesis and Properties per Georg Wuitschik, Mark Rogers‐Evans, A. Buckl, Maurizio Bernasconi, Moritz Märki, Thierry Godel, Holger Fischer, Björn Wagner, I. Parrilla, Franz Schuler, Josef Schneider, André Alker, W. Bernd Schweizer, Klaus Müller, Erick M. Carreira
Publicat 2008Artigo -
3
NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS per Najwa Ouali Alami, Christine Schurr, Florian olde Heuvel, Linyun Tang, Qian Li, Alpaslan Tasdogan, Atsushi Kimbara, Matthias Nettekoven, Giorgio Ottaviani, Catarina Raposo, Stephan Röver, Mark Rogers‐Evans, Benno Rothenhäusler, Christoph Ullmer, Jürgen Fingerle, Uwe Grether, Irène Knuesel, Tobias M. Boeckers, Albert C. Ludolph, Thomas Wirth, Francesco Roselli, Bernd Baumann
Publicat 2018Artigo
Eines de cerca:
Matèries relacionades
Biology
Chemistry
Medicine
Amyotrophic lateral sclerosis
Antagonist
Astrocyte
Biochemistry
Biotechnology
Catalysis
Central nervous system
Disease
EMPA
Electron microprobe
Electrophile
Endocrinology
Immune system
Immunology
In vivo
Inflammation
Inositol
Internal medicine
Microglia
Mineralogy
Morpholine
Neuropeptide
Neuroprotection
Neuroscience
Orexin
Orexin receptor
Orexin-A